Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Farmers Insurance
Moodys
AstraZeneca
Cerilliant
UBS
Argus Health
Daiichi Sankyo
McKinsey

Generated: October 20, 2017

DrugPatentWatch Database Preview

Mechanism of Action: Androgen Receptor Antagonists

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas
XTANDI
enzalutamide
CAPSULE;ORAL203415-001Aug 31, 2012RXYesYes► Subscribe► SubscribeYY ► Subscribe
Astellas
XTANDI
enzalutamide
CAPSULE;ORAL203415-001Aug 31, 2012RXYesYes► Subscribe► Subscribe► Subscribe
Astellas
XTANDI
enzalutamide
CAPSULE;ORAL203415-001Aug 31, 2012RXYesYes► Subscribe► Subscribe► Subscribe
Astellas
XTANDI
enzalutamide
CAPSULE;ORAL203415-001Aug 31, 2012RXYesYes► Subscribe► Subscribe ► Subscribe
Astellas
XTANDI
enzalutamide
CAPSULE;ORAL203415-001Aug 31, 2012RXYesYes► Subscribe► Subscribe ► Subscribe
Ani Pharms Inc
NILUTAMIDE
nilutamide
TABLET;ORAL207631-001Jul 15, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
NILANDRON
nilutamide
TABLET;ORAL020169-001Sep 19, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
NILANDRON
nilutamide
TABLET;ORAL020169-002Apr 30, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
Par Pharm
FLUTAMIDE
flutamide
CAPSULE;ORAL075298-001Sep 18, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
FLUTAMIDE
flutamide
CAPSULE;ORAL075780-001Sep 19, 2001ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Chinese Patent Office
Fish and Richardson
Moodys
Colorcon
Queensland Health
Federal Trade Commission
Chubb
Julphar
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot